These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6150501)

  • 1. Action of oxmetidine on the rabbit aorta: comparison with some calcium entry blockers and nitroglycerin.
    Bertaccini G; Poli E; Raddino R
    Pharmacol Res Commun; 1984 Feb; 16(2):161-70. PubMed ID: 6150501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac effects of the new H2-receptor antagonists.
    Coruzzi G; Poli E; Bertaccini G
    Agents Actions; 1983 Apr; 13(2-3):173-8. PubMed ID: 6135322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium entry blockers not connected with calcium channels inhibition.
    Raddino R; Poli E; Ferrari R; Visioli O
    Gen Pharmacol; 1987; 18(4):431-6. PubMed ID: 2440761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of the new H2-receptor antagonist oxmetidine on the duodenum of different species.
    Coruzzi G; Bertaccini G
    Scand J Gastroenterol Suppl; 1989; 167():93-6. PubMed ID: 2575790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxant effect of the H2-receptor antagonist oxmetidine on guinea-pig and human airways.
    Advenier C; Gnassounou JP; Scarpignato C
    Br J Pharmacol; 1987 Mar; 90(3):523-30. PubMed ID: 2882803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HNS-32, a novel azulene-1-carboxamidine derivative, inhibits nifedipine-sensitive and -insensitive contraction of the isolated rabbit aorta.
    Tanaka Y; Mitani A; Igarashi T; Someya S; Otsuka K; Imai T; Yamaki F; Tanaka H; Saitoh M; Nakazawa T; Noguchi K; Hashimoto K; Shigenobu K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):344-52. PubMed ID: 11284450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mode of vasorelaxant action of 2-aminoisoquinoline, 1.3 (2H.4H)-dione, a novel 'intracellular calcium inhibitor'.
    Hester RK; Satake N; Shibata S; Ueda S; Yamahara J
    Br J Pharmacol; 1986 Feb; 87(2):387-93. PubMed ID: 3082401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological activity of the new calcium antagonist, lacidipine, on isolated preparations.
    Raddino R; Metra M; Nodari S; Pelá G; Fappani A; Dei Cas L
    Gen Pharmacol; 1996 Oct; 27(7):1255-9. PubMed ID: 8981077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilation profile of CD-832, a novel dihydropyridine derivative in rabbit aorta.
    Noguchi K; Takahashi K; Araki H; Higuchi S
    Gen Pharmacol; 1997 Sep; 29(3):361-6. PubMed ID: 9378240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the calcium channel facilitator, CGP 28,392, on different modes of contraction in smooth muscle of rabbit and rat aortae and guinea-pig taenia caeci.
    Karaki H; Nagase H; Ozaki H; Urakawa N; Weiss GB
    Br J Pharmacol; 1986 Oct; 89(2):423-9. PubMed ID: 3779218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of calcium antagonists on intracellular calcium deposits].
    Raddino R; Poli E; Pelà G; Ferrari A; Ghirarduzzi A; Ferrari R
    Cardiologia; 1987 Apr; 32(4):395-9. PubMed ID: 3113731
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of papaverine, D600, and nifedipine on the effects of noradrenaline and calcium on the isolated aorta and mesenteric artery of the rabbit.
    Schümann HJ; Görlitz BD; Wagner J
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(4):409-18. PubMed ID: 1161061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo.
    Hof RP; Scholtysik G
    J Cardiovasc Pharmacol; 1983; 5(2):176-83. PubMed ID: 6188886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of vasorelaxing action of 5-[3-[[2-(3,4-dimethoxyphenyl)-ethyl]amino]-1-oxopropyl]-2,3,4,5- tetrahydro-1,5-benzothiazepine fumarate (KT-362), a new intracellular calcium antagonist.
    Shibata S; Wakabayashi S; Satake N; Hester RK; Ueda S; Tomiyama A
    J Pharmacol Exp Ther; 1987 Jan; 240(1):16-22. PubMed ID: 3100766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxation of large coronary artery by verapamil, D600, and nifedipine is constrictor selective: comparison with glyceryl trinitrate.
    Angus JA; Brazenor RM
    J Cardiovasc Pharmacol; 1983; 5(2):321-8. PubMed ID: 6188910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that oxmetidine inhibits transmembrane-calcium flux in cardiac and vascular tissue.
    Gristwood RW; Jim KF; Macia RA; Matthews WD; Morl CJ; Owen DA
    Br J Pharmacol; 1985 Aug; 85(4):923-32. PubMed ID: 4041684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of calcium channel antagonists with parietal cell acid production, adenylate cyclase, intracellular-free Ca2+ and H+/K+-ATPase.
    Beil W; Bersimbaev RJ; Hannemann H; Sewing KF
    Pharmacology; 1990; 40(1):8-20. PubMed ID: 2158665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of the calcium entry blockers, verapamil, diltiazem and flunarizine against contractions of the rat isolated aorta and portal vein.
    Marriott JF
    Br J Pharmacol; 1988 Sep; 95(1):145-54. PubMed ID: 3219471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the calcium-antagonistic effects of terodiline, nifedipine and verapamil.
    Larsson-Backström C; Arrhenius E; Sagge K
    Acta Pharmacol Toxicol (Copenh); 1985 Jul; 57(1):8-17. PubMed ID: 4050455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of depolarization on vasorelaxant potency and efficacy of Ca2+ entry blockers, K+ channel openers, nitrate derivatives, salbutamol and papaverine in rat aortic rings.
    Magnon M; Calderone V; Floch A; Cavero I
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):452-63. PubMed ID: 9826068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.